| Literature DB >> 27242763 |
Daniela Hellwig1, Jessica Voigt1, Maria Bouzani2, Jürgen Löffler2, Daniela Albrecht-Eckardt3, Michael Weber1, Sascha Brunke4, Ronny Martin1, Oliver Kurzai1, Kerstin Hünniger1.
Abstract
As part of the innate immune system, natural killer (NK) cells are directly involved in the response to fungal infections. Perforin has been identified as the major effector molecule acting against many fungal pathogens. While several studies have shown that perforin mediated fungicidal effects can contribute to fungal clearance, neither the activation of NK cells by fungal pathogens nor the effects of perforin on fungal cells are well-understood. In a dual approach, we have studied the global gene expression pattern of primary and cytokine activated NK cells after co-incubation with Candida albicans and the transcriptomic adaptation of C. albicans to perforin exposure. NK cells responded to the fungal pathogen with an up-regulation of genes involved in immune signaling and release of cytokines. Furthermore, we observed a pronounced increase of genes involved in glycolysis and glycolysis inhibitor 2-deoxy-D-glucose impaired C. albicans induced NK cell activation. This strongly indicates that metabolic adaptation is a major part of the NK cell response to C. albicans infections. In the fungal pathogen, perforin induced a strong up-regulation of several fungal genes involved in the zinc depletion response, such as PRA1 and ZRT1. These data suggest that fungal zinc homeostasis is linked to the reaction to perforin secreted by NK cells. However, deletion mutants in PRA1 and ZRT1 did not show altered susceptibility to perforin.Entities:
Keywords: Candida albicans; NK cells; glycolysis; perforin; zinc
Year: 2016 PMID: 27242763 PMCID: PMC4872603 DOI: 10.3389/fmicb.2016.00750
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
KEGG categories significantly overrepresented in differently expressed genes of primary and cytokine activated NK cells (NKC) challenged with Candida albicans.
| KEGG | Term | # of genes | Genes | |
|---|---|---|---|---|
| Hsa00010 | Glycolysis/gluconeogenesis | 7 | 0.00014 | LDHA, PGAM4, ALDOC, PGAM1, HK2, ENO2, PFKP |
| Hsa04060 | Cytokine–cytokine receptor interaction | 13 | 0.00017 | CSF2, IL3, IL8, IL21R, CCL4L1, TNFSF9, CCL4, CCL14, CCL3L1, CX3CR1, IFNG, VEGFA, XCL1 |
| Hsa04062 | Chemokine signaling pathway | 5 | 0.020 | CXCL1, CCL3, IL8, CCR1, PRKACB |
| Hsa04110 | Cell cycle | 10 | 0.0015 | E2F2, CDKN1A, GADD45G, TTK, CDK6, CDC20, CDC25C, GADD45B, MYC, CDC25B |
| Hsa04010 | MAPK signaling pathway | 15 | 0.0018 | PRKCA, TNF, MAP2K3, FASLG, NR4A1, CDC25B, DUSP5, DUSP4, DUSP2, NTRK1, MAP3K8, GADD45G, GADD45B, MYC, DUSP6 |
| Hsa00010 | Glycolysis/gluconeogenesis | 6 | 0.0095 | GPI, PKM2, HK1, PGK1, GAPDHL6, ALDH3A2 |
| Hsa04650 | Natural killer cell mediated cytotoxicity | 8 | 0.0255 | PRKCA, ICAM1, CD244, TNF, PIK3CD, NFAT5, FASLG, NFATC1 |
| Hsa04060 | Cytokine–cytokine receptor interaction | 12 | 0.02686 | CCL1, LIF, TNFRSF9, TNF, TNFRSF12A, CLCF1, CXCL16, TNFSF14, FASLG, CCL4L2, KIT, LTA |